Antiparasitic Drugs Market, by Drug Class (Anthelmintics (Benzimidazoles, Pyrantel, Niclosamide, Praziquantel, and Others), Antiprotozoals (Antimalarial Drugs-Aminoquinolines, Quinoline-methanol (4-quinolinemethanols), Cinchona Alkaloids, Biguanides, Sulf

Antiparasitic Drugs Market, by Drug Class (Anthelmintics (Benzimidazoles, Pyrantel, Niclosamide, Praziquantel, and Others), Antiprotozoals (Antimalarial Drugs-Aminoquinolines, Quinoline-methanol (4-quinolinemethanols), Cinchona Alkaloids, Biguanides, Sulfonamides and sulfones, Others), and Other Antiprotozoal Agents), and Others (Pediculocides & miticulocides) (Lindane, Malathion, Pyrethrins, and Others), by Route of Administration (Oral, Injectable, and Topical), by Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) - Size, Share, Outlook, and Opportunity Analysis, 2022 - 2028

Parasites are the living organisms found on the host body. There are three type of parasites; protozoa, helminths, and ectoparasites, which can cause parasitic infections in humans. Malaria, Chagas disease, Echinococcosis, Trichomoniasis, Amebiasis, etc., are some of the common parasitic infections affecting the human health. Among these, malaria is considered as a deadly infectious disease affecting the population in both tropical and subtropical regions. Different types of antiparasitic drugs are available in the market for treating such parasitic infections.
Market Dynamics
Malaria, which is caused due to the bite of infected female anopheles mosquito, is considered as a life-threatening infectious disease affecting a large number of people across the world. According to the World Health Organization (WHO), in 2018, around 228 million cases of malaria were diagnosed globally. Moreover, the global death toll due to malaria reached 405,000 in 2018 and an estimated 219 million cases were diagnosed in 2017. Sub-Saharan Africa is the most affected region by malaria and according to WHO estimation, the region accounted for 93% of malaria cases among all the global cases. Thus, the increasing incidence of malaria in the world is expected to drive demand for antimalarial drugs, and thereby drive the growth of the antiparasitic drugs market during the forecast period.
Moreover, various pharmaceutical companies and research institutes are actively participating in research and development of novel drugs for treatment of parasitic infections. For instance, in August 2021, Insud Pharma (in collaboration with Chemo Research S.L.) initiated Phase 3 clinical trial to evaluate the efficacy/safety and population pharmacokinetics of Benznidazole in children with chronic indeterminate Chagas Disease. The study is estimated to complete in March 2027.
Key features of the study:
This report provides in-depth analysis of the global antiparasitic drugs market, market size (US$ Mn), and compound annual growth rate (CAGR %) over the forecast period (2022-2028), considering 2021 as the base year
It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
This study also provides key insights about market drivers, restraints, opportunities, new technology launches or approvals, market trends, regional outlook, and competitive strategies adopted by leading players
It profiles leading players in the global antiparasitic drugs market based on the following parameters: company overview, financial performance, technology portfolio, geographical presence, distribution strategies, key developments, and strategies
Key players covered as a part of this study are Ipca Laboratories Ltd., Zydus Cadila, Merck KGaA, Pfizer, GlaxoSmithKline Plc., Cipla Ltd, Ranbaxy Laboratories, Novartis AG, Alvizia Health Care, Bayer AG, Roche Inc., Arbor Pharmaceuticals Inc., Sanofi, AstraZeneca plc., and Alkem Laboratories Limited
Insights from this report would allow marketers and management authorities of companies to make informed decision with respect to future technology launches, governmental initiatives, technological up-gradation, market expansions, and marketing tactics
The global antiparasitic drugs market report caters to various stakeholders in this market, including investors, technology manufacturers, distributors, and suppliers in the global anti-malarial drugs industry, research and consulting firms, new entrants, and financial analysts
Detailed Segmentation:
Global Antiparasitic Drugs Market, By Drug Class:
Anthelmintics
Benzimidazoles
Pyrantel
Niclosamide
Praziquantel
Others
Antiprotozoals
Antimalarial Drugs
Aminoquinolines
Quinoline-methanol (4-quinolinemethanols)
Cinchona Alkaloids
Biguanides
Sulfonamides and sulfones
Others
Other Antiprotozoal Agents
Others (Ectoparasites, Pediculocides & miticulocides)
Lindane
Malathion
Pyrethrins
Others
Global Antiparasitic Drugs Market, By Route of Administration:
Oral
Injectable
Topical
Global Antiparasitic Drugs Market, By Distribution Channel:
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
Global Antiparasitic Drugs Market, By Region:
North America
By Country:
U.S.
Canada
By Drug Class:
Anthelmintics
Benzimidazoles
Pyrantel
Niclosamide
Praziquantel
Others
Antiprotozoals
Antimalarial Drugs
Aminoquinolines
Quinoline-methanol (4-quinolinemethanols)
Cinchona Alkaloids
Biguanides
Sulfonamides and sulfones
Others
Other Antiprotozoal Agents
Others (Ectoparasites, Pediculocides & miticulocides)
Lindane
Malathion
Pyrethrins
Others
By Route of Administration:
Oral
Injectable
Topical
By Distribution Channel
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
Europe
By Country:
U.K.
Germany
Italy
Spain
France
Russia
Rest of Europe
By Drug Class:
Anthelmintics
Benzimidazoles
Pyrantel
Niclosamide
Praziquantel
Others
Antiprotozoals
Antimalarial Drugs
Aminoquinolines
Quinoline-methanol (4-quinolinemethanols)
Cinchona Alkaloids
Biguanides
Sulfonamides and sulfones
Others
Other Antiprotozoal Agents
Others (Ectoparasites, Pediculocides & miticulocides)
Lindane
Malathion
Pyrethrins
Others
By Route of Administration:
Oral
Injectable
Topical
By Distribution Channel
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
Asia Pacific
By Country:
Australia
India
China
Japan
ASEAN
South Korea
Rest of Asia Pacific
By Drug Class:
Anthelmintics
Benzimidazoles
Pyrantel
Niclosamide
Praziquantel
Others
Antiprotozoals
Antimalarial Drugs
Aminoquinolines
Quinoline-methanol (4-quinolinemethanols)
Cinchona Alkaloids
Biguanides
Sulfonamides and sulfones
Others
Other Antiprotozoal Agents
Others (Ectoparasites, Pediculocides & miticulocides)
Lindane
Malathion
Pyrethrins
Others
By Route of Administration:
Oral
Injectable
Topical
By Distribution Channel
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
Latin America
By Country:
Brazil
Mexico
Argentina
Rest of Latin America
By Drug Class:
Anthelmintics
Benzimidazoles
Pyrantel
Niclosamide
Praziquantel
Others
Antiprotozoals
Antimalarial Drugs
Aminoquinolines
Quinoline-methanol (4-quinolinemethanols)
Cinchona Alkaloids
Biguanides
Sulfonamides and sulfones
Others
Other Antiprotozoal Agents
Others (Ectoparasites, Pediculocides & miticulocides)
Lindane
Malathion
Pyrethrins
Others
By Route of Administration:
Oral
Injectable
Topical
By Distribution Channel
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
Middle East
By Country:
GCC
Israel
Rest of Middle East
By Drug Class:
Anthelmintics
Benzimidazoles
Pyrantel
Niclosamide
Praziquantel
Others
Antiprotozoals
Antimalarial Drugs
Aminoquinolines
Quinoline-methanol (4-quinolinemethanols)
Cinchona Alkaloids
Biguanides
Sulfonamides and sulfones
Others
Other Antiprotozoal Agents
Others (Ectoparasites, Pediculocides & miticulocides)
Lindane
Malathion
Pyrethrins
Others
By Route of Administration:
Oral
Injectable
Topical
By Distribution Channel
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
Africa
By Country/Region:
South Africa
Central Africa
North Africa
By Drug Class:
Anthelmintics
Benzimidazoles
Pyrantel
Niclosamide
Praziquantel
Others
Antiprotozoals
Antimalarial Drugs
Aminoquinolines
Quinoline-methanol (4-quinolinemethanols)
Cinchona Alkaloids
Biguanides
Sulfonamides and sulfones
Others
Other Antiprotozoal Agents
Others (Ectoparasites, Pediculocides & miticulocides)
Lindane
Malathion
Pyrethrins
Others
By Route of Administration:
Oral
Injectable
Topical
By Distribution Channel
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
Company Profiles
Ipca Laboratories Ltd.,*
Company Overview
Product Portfolio
Financial Performance
Recent Highlights
Strategies
Zydus Cadila
Merck KGaA
Pfizer
GlaxoSmithKline Plc.
Cipla Ltd
Ranbaxy Laboratories
Novartis AG
Alvizia Health Care
Bayer AG
Roche Inc.
Arbor Pharmaceuticals Inc.
Sanofi
AstraZeneca plc.
Alkem Laboratories Limited
“*” marked represents similar segmentation in other categories in the respective section